Montag & Caldwell’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-49
Closed -$4.4K 126
2025
Q1
$4.4K Hold
49
﹤0.01% 121
2024
Q4
$3.91K Buy
+49
New +$4.24K ﹤0.01% 131
2017
Q3
Sell
-612,185
Closed -$54.3M 88
2017
Q2
$54.3M Sell
612,185
-305,430
-33% -$25.8M 1.6% 30
2017
Q1
$73.9M Sell
917,615
-272,281
-23% -$21.3M 2.12% 25
2016
Q4
$84.8M Sell
1,189,896
-1,343,332
-53% -$106M 2.05% 27
2016
Q3
$219M Buy
2,533,228
+214,528
+9% +$18.7M 4.6% 5
2016
Q2
$201M Buy
2,318,700
+324,802
+16% +$26.3M 4.1% 7
2016
Q1
$150M Buy
+1,993,898
New +$150M 2.74% 16
2015
Q1
Sell
-3,150
Closed -$227K 113
2014
Q4
$227K Buy
+3,150
New +$219K ﹤0.01% 110
2014
Q3
Sell
-3,150
Closed -$201K 107
2014
Q2
$201K Buy
+3,150
New +$191K ﹤0.01% 101

Other funds holding MDT

Montag & Caldwell's MDT Position: Q2 2025 in Review

Montag & Caldwell sold out of Medtronic (MDT) in Q2 2025, closing a stake of 49 shares — an estimated $4.4K sold.

Montag & Caldwell first reported a position in MDT in Q2 2014 and held it in 10 quarters. The position peaked at $219M in Q3 2016. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Montag & Caldwell reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Montag & Caldwell sold 49 Medtronic shares in Q2 2025, an estimated $4.4K.
  • Montag & Caldwell first reported a position in Medtronic in Q2 2014 and held it in 10 quarters.
  • Montag & Caldwell's Medtronic position peaked at $219M in Q3 2016.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Montag & Caldwell's 13F filing for Q2 2025, filed 15 Aug 2025.